During the last three months, 4 analysts shared their evaluations of Adaptimmune Therapeutics ADAP +4.03% Get Free Report , ...

Rivian CEO RJ Scaringe shared positive comments on Tesla while speaking at the LA Auto Show, calling the Model Y the best EV ...

Since its inception, the Giving Machines have touched the lives of countless individuals. In 2023 alone, over 600,000 people ...

According to Benzinga Pro, Jackson Finl's peer group average for short interest as a percentage of float is 1.63%, which ...

Investors with a lot of money to spend have taken a bearish stance on Netflix NFLX. And retail traders should know. We ...

Mitchell DiRaimondo, co-founder of SteelWave, discussed the rise of traditional financial institutions' interest in ...

Analysts on Monday drew parallels between Bitcoin's (CRYPTO: BTC) recent performance and its infamous "Thanksgiving Day ...

Trump's proposed tariffs on Mexico causing Nvidia and Intel suppliers to reassess manufacturing strategies, impacting stock ...

Outlook Therapeutics reports ONS-5010 missed noninferiority endpoint in NORSE EIGHT trial for wet AMD but showed vision ...

Adjusted EBITDA was a gain of $148,128 compared to adjusted EBITDA loss of $32,622 in the third quarter of last year.

Vasily Shikin, Chief Technology Officer at AppLovin APP, executed a substantial insider sell on November 26, according to an ...

Kronos Bio announces major leadership changes and an 83% workforce reduction as part of a strategic overhaul, with stock ...